Minor
Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination · Advanced Solid Tumors
Trial sites expanded: 47 → 55 locations
Vividion Therapeutics, Inc.Phase 1 NCT06004245 Registry history of NCT06004245 on ClinicalTrials.gov (opens the registry)